HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Spinocerebellar ataxia 21

Also Known As:

SCA21 Spinocerebellar ataxia 21

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Nervous System Diseases: 14178
- Neurodegenerative Diseases: 42472
  - Nervous System Heredodegenerative Disorders: 63
    - Spinocerebellar Degenerations: 353
      - Spinocerebellar ataxia 21: 2
- Central Nervous System Diseases: 4213
  - Brain Diseases: 15694
    - Cerebellar Diseases: 631
      - Spinocerebellar Degenerations: 353
        Spinocerebellar ataxia 21: 2
  - Spinal Cord Diseases: 4314
    - Spinocerebellar Degenerations: 353
      - Spinocerebellar ataxia 21: 2
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Nervous System Heredodegenerative Disorders: 63
    - Spinocerebellar Degenerations: 353
      - Spinocerebellar ataxia 21: 2

Experts

1.	Bergendal, Åsa: 1 article (06/2022)
2.	Daugeliene, Dalia: 1 article (06/2022)
3.	Kvarnung, Malin: 1 article (06/2022)
4.	Paucar, Martin: 1 article (06/2022)
5.	Svenningsson, Per: 1 article (06/2022)
6.	van der Put, Johanna: 1 article (06/2022)
7.	Buée, Luc: 1 article (06/2020)
8.	Deramecourt, Vincent: 1 article (06/2020)
9.	Eddarkaoui, Sabiha: 1 article (06/2020)
10.	Faivre, Emilie: 1 article (06/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Spinocerebellar ataxia 21:

1.

Proteins (Proteins, Gene)FDA Link

06/01/2022 - "Spinocerebellar ataxia 21 (SCA21), a very rare autosomal dominant disease, was discovered to be associated with variants in the transmembrane protein 240 (TMEM240) gene in 2014. "
06/01/2020 - "A variety of missense mutations and a stop mutation in the gene coding for transmembrane protein 240 (TMEM240) have been reported to be the causative mutations of spinocerebellar ataxia 21 (SCA21). "